About
Dr. Milad Riazifar conducted Ph.D. research on exosomes at the Stem Cell Research Center at UC Irvine, focusing on cell-free exosome approaches for Multiple Sclerosis treatment. He subsequently contributed to clinical translation efforts at City of Hope, where he worked on a trial using stem cell exosomes for type 1 diabetes treatment.
Founder at Entelexo BiotherapeuticsYC W21
Intro paths
YC
MILAD went through Y Combinator (Winter 2021) — any YC alum in your network can reach them through the YC community.
→
In turn, MILAD can intro founders to Entelexo Biotherapeutics's investors below.
Entelexo Biotherapeutics's investors · 1
Co-founders at Entelexo Biotherapeutics
TS
Todd SchurrFounder
CT
Cameron TaylorFounder